65,437 trials
Myopia
Primary: Lens Awareness — 16; 12; 11; 9 Participants
Smoking
Primary: Number of Subjects Biochemically Confirmed to be Abstinent From Smoking at End of Treatment. — 1; 4 participants — p=0.973
Prostate Cancer
Primary: Percentage of Subjects With Suppression of Serum Testosterone (<=50 ng/dL) From Week 4 to Week 48 for Formulation A: Intent-to-treat (ITT) Population for the Primary…
Hypersensitivity
Primary: Duration of Suppressive Effect of Desloratadine After Discontinuation of a 1-week Treatment — 5; 4; NA Days
Healthy
Primary: Percentage of Participants Who Shed Any Vaccine Virus — 88.9; 69.0 percentage of participants
Prostate Cancer
Primary: Time to Objective Disease Progression — 11.7; 10.0 Weeks — p=0.052
Bipolar Disorder
Primary: Time to Recurrence of a Mood Episode (Risperidone LAI Versus Placebo) — 293.39; 270.47 days — p=0.057
Colonoscopy · Bowel Preparation
Primary: Maximum Observed Concentration (Cmax) — 717.0; 499.5; 560.2 µmol/L
Asthma
Primary: The Area Under the Curve From 0 to 12 Hours [AUC](0-12 hr) of the Change From Baseline to the Week 12 Endpoint in Forced Expiratory Volume in One Second (FEV1) — 3.43…
Leprosy
Primary: Number of Participants With Reactions to the Antigen Mycobacterium (M.) Leprae Soluble Antigen (MLSA)-Lipoarabinomannan (LAM) at Doses of 0.1 Microgram — 0; 3; 1; 5…
Presbyopia
Primary: Corrected Distance Binocular Visual Measurement in Normal Illumination Reported as Binocular Distance Visual Acuity — 0.00; -0.02 logMAR
Presbyopia
Primary: Corrected Distance Binocular Visual Measurement in Normal Illumination Reported as Binocular Distance Visual Acuity — -0.01; 0.01 logMAR
Cataract Extraction
Primary: The Aqueous Humor Drug Concentration. — 0.1349; 0.6681; 0.1251 µg/mL
Infections, Streptococcal · Streptococcus Pneumoniae
Primary: Concentrations of Antibodies Against Vaccine Pneumococcal Serotypes — 3.27; 0.03; 3.80; 0.04 µg/mL
Asthma, Exercise-Induced
Primary: Maximum Percent Fall in FEV1 After Exercise Challenge at 2 Hours Post-dose Compared With Pre-exercise Baseline in Patients With Exercise-induced Bronchospasm (EIB)…